Navigation Links
NIH grant will allow researchers to look for viral cause of most severe form of multiple sclerosis

SALT LAKE CITY A team of investigators from the University of Utah has received a two-year, $275,000 grant from the National Institutes of Health (NIH) to fund novel research that may help to uncover a viral cause for the most acute and severe form of multiple sclerosis. These studies will use an advanced technology called deep sequencing to analyze brain tissue from patients who died of primary progressive multiple sclerosis.

Multiple sclerosis (MS), which affects an estimated 400,000 people in the United States, is an autoimmune disease that leads to nerve damage in the brain and spinal cord. This damage is caused by inflammation that occurs when the body's own immune system attacks the myelin sheath, a fatty protective covering that surrounds nerve cells. Loss of myelin affects the ability of nerve cells in the brain and spinal cord to conduct the electrical signals needed for them to communicate with each other. To date, it is not known what prompts the damaging inflammation, but many investigators believe there is an environmental trigger, possibly a viral or other infection.

"Our preliminary data has already led to identification of a virus in the brain of one patient who died of primary progressive MS," says John D. Kriesel, M.D., research associate professor in the Division of Infectious Diseases at the University of Utah School of Medicine. "Using a technology called deep sequencing, we will now be studying brain tissue from a group of primary progressive MS patients, with the hope of isolating one or more viruses that might prove to be the cause of this severe type of MS."

Deep sequencing, otherwise known as high-throughput sequencing, is a technology that allows scientists to sequence very large amounts of DNA more quickly and at a lower cost than traditional sequencing methods. Kriesel and his colleagues will utilize deep sequencing to study the brain tissue of 15 patients who died of primary progressive MS and compare it to brain tissue from a population of controls, including normal patients and people with other neurologic diseases.

The sequencing data generated will then be analyzed for viral genetic material in order to identify viruses that are unique to the brain tissue of people with primary progressive MS.

MS is classified into four types, which differ in symptom intensity and rate of disease progression. While treatment has been effective for some forms of MS, the standard medications for MS have not been shown to slow the progression of neurologic decline in people with primary progressive multiple sclerosis (PPMS). Identifying viruses that might play a role in the development of PPMS could eventually lead to the development of screening tests, prevention, or anti-viral treatments for the disease.

"Currently, there is no approved or highly effective treatment for PPMS," says Kriesel. "The goal of our research is to define a cause for PPMS, so that future investigation can be directed at developing medicines that can slow or stop the progression of this devastating neurologic disease."


Contact: John D. Kriesel, M.D.
University of Utah Health Sciences

Related biology news :

1. UNH researchers receive NSF grant to scale up stream ecology
2. FDA grant launches Atlanta Pediatric Device Consortium
3. UofL researcher awarded $2.6 million NIH grant renewal
4. Danforth Plant Science Center awarded major bioenergy grant from US Department of Energy
5. Disney Worldwide Conservation Fund awards grant to R.J. Dunlap Marine Conservation Program
6. UMass Amherst wins major grant to host $7.5 million Northeast Climate Science Center
7. Institute for Genomic Biology, School of Integrative Biology receive major NSF training grant
8. Louisiana Tech University receives $1.1 million EDA grant to support green innovations
9. UNC spin-off receives $3 million Small Business Innovation Research Grant
10. Woody biomass research grant to launch biofuel industry in the Pacific Northwest
11. Stanford Precourt Institute and TomKat Center award energy research grants
Post Your Comments:
(Date:6/27/2016)... -- Research and Markets has announced the addition of ... their offering. The report forecasts ... grow at a CAGR of 12.28% during the period 2016-2020. ... market analysis with inputs from industry experts. The report covers the ... report also includes a discussion of the key vendors operating in ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Alex,s Lemonade Stand Foundation (ALSF), a leading national ... a state-of-the-art bioinformatics lab, using ,big data, to advance ... as Liz Scott , co-executive director of ALSF ... in Washington, D.C. , hosted by ... advocate of pediatric cancer research and awareness. ...
(Date:6/27/2016)...  Global demand for enzymes is forecast to ... $7.2 billion.  This market includes enzymes used in ... production, animal feed, and other markets) and specialty ... and beverages will remain the largest market for ... products containing enzymes in developing regions.  These and ...
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... to enabling healthier lives through the development of innovative ... of the United States denied ... that the claims of Sequenom,s U.S. Patent No. 6,258,540 ... eligibility criteria established by the Supreme Court,s Mayo Collaborative ...
Breaking Biology Technology: